title: Letter: proton pump inhibitors, hypergastrinaemia and the risk of gastric neoplasia.
authors.affiliation: Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway. helge.waldum@ntnu.no.|Department of Gastroenterology and Hepatology, St.Olavs Hospital, Trondheim, Norway. helge.waldum@ntnu.no.
authors.forename: H L
authors.initials: HL
authors.lastname: Waldum
authors.affiliation: Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.|Department of Gastroenterology and Hepatology, St.Olavs Hospital, Trondheim, Norway.
authors.forename: Ø
authors.initials: Ø
authors.lastname: Hauso
authors.affiliation: Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.|Department of Gastroenterology and Hepatology, St.Olavs Hospital, Trondheim, Norway.
authors.forename: R
authors.initials: R
authors.lastname: Fossmark
mesh_terms: D064098:Esomeprazole / Q000009:adverse effects*; D005260:Female; D005764:Gastroesophageal Reflux / Q000188:drug therapy*; D006801:Humans; D008297:Male; D009853:Omeprazole / Q000009:adverse effects*; D054328:Proton Pump Inhibitors / Q000009:adverse effects*
chemical_list: D054328:Proton Pump Inhibitors; D009853:Omeprazole; D064098:Esomeprazole